Category Archives: Business of Biotech

Warning: Don’t Let Bio-Euphoria Distract You from Being Disciplined

DNA

This piece by Allan L. Shaw was originally published in Life Science Leader. We currently in a period I call “bio-euphoria,” in which the biopharmaceutical industry is experiencing growth in almost every area from market performance to patient-focused legislation. In parallel to this positive momentum, there has also been a notable shift in management and operational strategy by Big Pharma companies in an attempt to keep evolving with the market. These companies are taking creative Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , ,

Discover Trends and Investment Opportunities at the BIO Investor Forum

hyde pier

The 2015 BIO Investor Forum in San Francisco is shaping up to be a must-attend event for private equity and public investors, research analysts, and industry executives focused on investment and business development opportunities in the life sciences. The Forum will include candid fireside chats between biopharma CEOs, analysts, and other industry experts. Come hear about recent company successes, what keeps the C-suite up at night, and where the industry’s leading companies are headed in 2016. Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

The Investment Landscape in Brazil

Rio de Janeiro, Brazil

Brazil has been at the forefront of biotech news recently, with China announcing plans to invest $250B and the recently signed Joint Communique with the U.S. government reaffirming their commitment to strengthening traditional ties, expand trade, and investment cooperation. Brazil is now one of the most attractive and promising biotech markets in the world—human health, agribusiness, raw materials and environmental—and investing in Brazil has become a new priority. Rather than leave innovation financing solely to Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,

Nominations Open: Be the Buzz of BIO at the 2015 BIO Investor Forum

Buzz of BIO contest, BIO Investor Forum

Nominations are now open for the Buzz of BIO at the 2015 BIO Investor Forum. The Buzz of BIO contest recognizes highly innovative companies in the biotech sector and helps position these companies to develop strategic partnerships within the industry. Ten biotechs will be nominated in each of two categories – Early Stage Entrepreneurs and Late Stage Leaders. Winners will then be chosen via online vote from August 24-28. The contest is an excellent opportunity for early-stage Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: ,

Watch-Out Tech Industry, Biotech is on the Rise in San Francisco

Golden Gate Bridge San Francisco, CA

When thinking about the industries that make up San Francisco’s vibrant economy, biopharma is often overshadowed by the Bay Area’s reputation as a tech hotspot. But in reality, health care outpaced the tech sector in 2014 by generating over $28 billion in economic activity and employing over 20% of San Francisco workers. The Bay Area is a hub of innovation for growing biotechs looking to connect with the right investors, which is why BIO chose Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,